These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 17973308)

  • 1. Difficulty of mode of action determination for trichloroethylene: An example of complex interactions of metabolites and other chemical exposures.
    Caldwell JC; Keshava N; Evans MV
    Environ Mol Mutagen; 2008 Mar; 49(2):142-54. PubMed ID: 17973308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxicological review of male reproductive effects and trichloroethylene exposure: assessing the relevance to human male reproductive health.
    Lamb JC; Hentz KL
    Reprod Toxicol; 2006 Nov; 22(4):557-63. PubMed ID: 16938429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Key issues in the modes of action and effects of trichloroethylene metabolites for liver and kidney tumorigenesis.
    Caldwell JC; Keshava N
    Environ Health Perspect; 2006 Sep; 114(9):1457-63. PubMed ID: 16966105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A proposed methodology for selecting a trichloroethylene inhalation unit risk value for use in risk assessment.
    Lewandowski TA; Rhomberg LR
    Regul Toxicol Pharmacol; 2005 Feb; 41(1):39-54. PubMed ID: 15649826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-dependent liver regeneration in chloroform, trichloroethylene and allyl alcohol ternary mixture hepatotoxicity in rats.
    Anand SS; Mumtaz MM; Mehendale HM
    Arch Toxicol; 2005 Nov; 79(11):671-82. PubMed ID: 15940471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trichloroethylene and cancer: epidemiologic evidence.
    Scott CS; Cogliano VJ
    Environ Health Perspect; 2000 May; 108 Suppl 2():159-60. PubMed ID: 10807549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trichloroethylene cancer risk: simplified calculation of PBPK-based MCLs for cytotoxic end points.
    Bogen KT; Gold LS
    Regul Toxicol Pharmacol; 1997 Feb; 25(1):26-42. PubMed ID: 9056499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trichloroethylene risk assessment: a review and commentary.
    Jollow DJ; Bruckner JV; McMillan DC; Fisher JW; Hoel DG; Mohr LC
    Crit Rev Toxicol; 2009; 39(9):782-97. PubMed ID: 19852561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comments on article "Applying mode-of-action and pharmacokinetic considerations in contemporary cancer risk assessments: an example with trichloroethylene" by Clewell and Andersen.
    Caldwell JC; Evans MV; Marcus AH; Scott CS; Chiu WA; Okino MS; Preuss PW
    Crit Rev Toxicol; 2006 Mar; 36(3):291-4; discussion 295-8. PubMed ID: 16686425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trichloroethylene: mechanisms of renal toxicity and renal cancer and relevance to risk assessment.
    Lock EA; Reed CJ
    Toxicol Sci; 2006 Jun; 91(2):313-31. PubMed ID: 16421178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trichloroethylene and ocular malformations: analysis of extant literature.
    Williams AL; DeSesso JM
    Int J Toxicol; 2008; 27(1):81-95. PubMed ID: 18293215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Renal cell carcinoma and exposure to trichloroethylene: are the French limits of occupational exposure relevant?].
    Charbotel B; Fevotte J; Martin JL; Bergeret A
    Rev Epidemiol Sante Publique; 2009 Feb; 57(1):41-7. PubMed ID: 19155150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a screening approach to interpret human biomonitoring data on volatile organic compounds: reverse dosimetry on biomonitoring data for trichloroethylene.
    Liao KH; Tan YM; Clewell HJ
    Risk Anal; 2007 Oct; 27(5):1223-36. PubMed ID: 18076492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A human physiologically based pharmacokinetic model for trichloroethylene and its metabolites, trichloroacetic acid and free trichloroethanol.
    Fisher JW; Mahle D; Abbas R
    Toxicol Appl Pharmacol; 1998 Oct; 152(2):339-59. PubMed ID: 9853003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trichloroethylene. II. Mechanism of carcinogenicity of trichloroethylene.
    Motohashi N; Nagashima H; Molnár J
    In Vivo; 1999; 13(3):215-9. PubMed ID: 10459494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trichloroethylene-contaminated drinking water and congenital heart defects: a critical analysis of the literature.
    Watson RE; Jacobson CF; Williams AL; Howard WB; DeSesso JM
    Reprod Toxicol; 2006 Feb; 21(2):117-47. PubMed ID: 16181768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applying mode-of-action and pharmacokinetic considerations in contemporary cancer risk assessments: an example with trichloroethylene.
    Clewell HJ; Andersen ME
    Crit Rev Toxicol; 2004; 34(5):385-445. PubMed ID: 15560567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of the relationship between trichloroethylene metabolism and tissue-specific toxicity among inbred mouse strains: liver effects.
    Yoo HS; Bradford BU; Kosyk O; Shymonyak S; Uehara T; Collins LB; Bodnar WM; Ball LM; Gold A; Rusyn I
    J Toxicol Environ Health A; 2015; 78(1):15-31. PubMed ID: 25424544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chloroethylene mixtures: pharmacokinetic modeling and in vitro metabolism of vinyl chloride, trichloroethylene, and trans-1,2-dichloroethylene in rat.
    Barton HA; Creech JR; Godin CS; Randall GM; Seckel CS
    Toxicol Appl Pharmacol; 1995 Feb; 130(2):237-47. PubMed ID: 7871537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.